CA Patent

CA2840242C — Methods for treating hcv

Assigned to Gilead Sciences Inc · Expires 2019-03-26 · 7y expired

What this patent protects

This invention relates to combinations of therapeutic molecules useful for treating hepatitis C virus infection. Particularly, it is provided a composition comprising a compound having the structure: (see structure I) or a pharmaceutically acceptable salt thereof, and a compound …

USPTO Abstract

This invention relates to combinations of therapeutic molecules useful for treating hepatitis C virus infection. Particularly, it is provided a composition comprising a compound having the structure: (see structure I) or a pharmaceutically acceptable salt thereof, and a compound having the structure: (see structure II) or a pharmaceutically acceptable salt thereof. The present invention further relates to methods, uses, dosing regimens, and compositions.

Drugs covered by this patent

Patent Metadata

Patent number
CA2840242C
Jurisdiction
CA
Classification
—
Expires
2019-03-26
Drug substance claim
No
Drug product claim
No
Assignee
Gilead Sciences Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.